Cryopreservation has a negative effect on the quality of oocytes and may be closely associated with increased levels of reactive oxygen species (ROS) and apoptotic events. The purpose of the present study was to evaluate the detrimental effects on the developmental competence of somatic cell nuclear transferred (SCNT) mouse embryos using vitrified (cryopreserved) oocytes and to evaluate the recovery effects of melatonin on cryo-damage in cloned embryos. Development of SCNT embryos using cryopreserved oocyte cytoplasm (SCNT-CROC) was inferior to those using fresh cytoplasm (SCNT-FOC). Using RNA-sequencing analysis, we found upregulation of eight pro-apoptotic-related genes (Cyct, Dapk2, Dffb, Gadd45g, Hint2, Mien1, P2rx7, and Pmaip) in the SCNT-CROC group. Furthermore, the addition of melatonin, an agent that reduces apoptosis and ROS production, enhanced blastocyst formation rates in the SCNT-CROP group when compared with the melatonin-untreated group. Additionally, melatonin treatment increased the derivation efficiency of pluripotent stem cells from cloned embryos using cryopreserved oocyte.
INTRODUCTION
It has been suggested that somatic cell nuclear transfer (SCNT)-based reprogramming and subsequent derivation of embryonic stem cells (ESCs) can produce patient-specific stem cells for regenerative medicine (Lanza et al., 1999) . Recently, three individual research groups have successfully derived several SCNT-ESC lines using good-quality human oocytes and fibroblast cells from various sources (Chung et al., 2014; Tachibana et al., 2013; Yamada et al., 2014) . In addition, many of the developmental blocks in human SCNT embryos have been partially overcome by modulation of histone methylation (Chung et al., 2015) and are now an applicable technology for cell therapy.
Recently, oocyte vitrification has been used as a practical tool in human assisted reproductive technology as well as a popular cryopreservation method. In fact, it was reported that cytogenetic and developmental deficits in offspring born from vitrified (cryopreserved) oocytes were not increased when compared with conventional in vitro fertilization (Practice Committees of American Society for Reproductive Medicine and Society for Assisted Reproductive Technology, 2013) . This technique provides a valuable opportunity to preserve fertility for infertile women, to treat fertile women at risk of age-induced fertility decline (Zhang et al., 2016) and cancer therapy-induced threats to fertility (Falcone et al., 2004) . In addition, vitrification of surplus human oocytes could provide a steady source of eggs for research, such as SCNT, and its use also reduces ethical concerns (Baek et al., 2017). However, although cryopreserved mouse oocytes can support genomic reprogramming of the somatic cell nucleus to permit full-term development, developmental potential of the SCNT embryos was very poor (Hirata et al., 2011). In particular, production of cloned embryos using cryopreserved human oocytes and derivation of their SCNT-ESC lines was not achieved until recently. Even with a survival rate greater than 90%, clinical outcomes from vitrified oocytes are lower than from fresh oocytes in the human assisted reproductive technology program (Nakagata et al., 2013) . This is suggested to be due to cytoskeletal damage (Hotamisligil et al., 1996) In the present study, we primarily explored the effect of vitrified oocyte cytoplasm on the outcome of SCNT-mediated reprogramming. By modulation of histone methylation, a developmental block was overcome in cloned embryos derived from both cryopreserved and fresh oocytes; however, the developmental capacity was greater in those from fresh oocytes. This deficit in embryonic development can be partly recovered by addition of melatonin during cultivation in vitro, as shown in cloned embryos derived from fresh oocytes. In fact, supplementation of melatonin may positively affect the quality of cloned embryos by regulating gene expression and apoptotic processes.
RESULTS
Injection of Kdm4a mRNA Enhanced Embryonic Development of Cloned Embryos Using Vitrified/ Warmed Oocytes, but Did Not Fully Reach that of Fresh Oocytes In our previous study, mRNA injection of Kdm4a encoding the H3K9me3 demethylase overcame a developmental block of SCNT mammalian eggs and improved their embryonic development (Chung et al., 2015) . To analyze the effect of Kdm4a mRNA on the development of cloned embryos using cytoplasm of vitrified/warmed oocytes, we assessed their embryonic development after injections with or without Kdm4a mRNA. The injection of Kdm4a mRNA removed H3K9me3 activity ( Figure S1 ) and overcame the 2-cell block in the cloned embryos (Table 1) . In fact, downregulation of H3K9me3 activity highly improved blastocyst formation rates in both cloned embryos using fresh (SCNT-FOC) and cryopreserved oocyte cytoplasm (SCNT-CROC). Interestingly, although developmental block was nearly overcome after Kdm4a mRNA injection in both groups, embryonic development and the quality of blastocysts from the SCNT-CROC group was still lower than those of the SCNT-FOC group ( Figure 1 and Table 1 ). As shown Figure 1C , the number of cloned embryos showing a high ratio of inner cell mass (ICM) number (more than 10 ICMs per blastocyst) was lower in the SCNT-CROC + K group than in the SCNT-FOC + K group (p < 0.05).
Analysis of Transcriptional Differences in Cloned 2-Cell Embryos between SCNT-FOC and SCNT-CROC Groups
To identify the earliest embryonic transcriptional differences between SCNT-FOC and SCNT-CROC groups, we performed RNA-sequencing (RNA-seq) experiments with pooled 2-cell embryos (100 embryos per sample, repeated three times) of both groups 24 h after oocyte activation and Kdm4a mRNA injection. The expression of most genes was similar in both groups, and only a small number of genes (159 genes) were shown to have different expression patterns ( Figure 2A ). From gene ontology (GO) terms and KEGG analysis, we found that several pathways, including apoptosis and p53 signaling pathways, were markedly activated. When the differentially expressed genes (DEGs) in the GO-term database were analyzed, out of 1,730 apoptosis-related genes only 16 genes (0.92%) showed greater than a 3-fold difference between SCNT-FOC and SCNT-CROC groups. Interestingly, in the SCNT-CROC group, eight (50%) pro-apoptosis-related genes (Cyct, Dapk2, Dffb, Gadd45g, Hint2, Mien1, P2rx7, and Pmaip) and three (27.2%) anti-apoptotic genes (Adrb2, Scin, and Six1) were upregulated when compared with the SCNT-FOC group. Also, only two (18.2%) pro-apoptosis-related genes (Ifng and Siah1a) and three (27.2%) anti-apoptotic genes (Syce3, Tsc22d3, and Vegfa) were downregulated ( Figure 2B ). In addition, only six cell-cycle-related genes (0.41% out of 1,449 genes) had different expression levels and only one cell arrest-related gene (Gadd45g) was upregulated in the SCNT-CROC group ( Figure 2B ).
On the other hand, 30 gene expression-related genes (0.62% out of 4,841 genes) and 61 metabolic processrelated genes (0.60% out of 10,234 genes) showed different expression between SCNT-FOC and SCNT-CROC groups.
However, most of them have no negative function on gene expression or metabolic process ( Figure 2B ).
Melatonin Enhances Embryonic Development of Cloned Embryos Using Vitrified/Warmed Oocytes Due to the low rate of embryonic development up to the blastocyst stage and different expressions of apoptotic genes in the SCNT-CROC group, we applied 10 mM melatonin to the culture system of cloned embryos to improve their quality. The concentration of melatonin resulting in the best quality and a high blastocyst formation rate was selected from a preliminary experiment using conventionally fertilized mouse embryos (data not shown). The overall percentage of TUNEL-positive embryos were significantly decreased in the melatonin-supplemented group (SCNT-CROC + K + M) compared with those of the non-supplemented group (SCNT-CROC and SCNT-CROC + K) (7.8% versus 54.3% and 24.1%, p < 0.05; Figures  3A and 3B ). In addition, melatonin has a positive role on the reduction of ROS levels and in the embryonic development of the SCNT-CROC group, regardless of Kdm4a mRNA injection (Table 2) . To compare the embryonic quality of cloned embryos with or without supplementation of melatonin, we analyzed the implantation rate after embryo transfer and the derivation rate of mouse ESCs (mESCs). The number of implantation rates in the melatonin-supplemented group (SCNT-CROC + K + M) was significantly increased compared with those of the non-supplemented group (SCNT-CROC + K) (66.2% [51/77] Figure 4B ).
Effect of Melatonin Treatment on Transcription in
Cloned Blastocysts from the SCNT-CROC Group To find which genes are regulated by melatonin, we analyzed transcripts from 2-cell embryos and blastocysts (50 embryos or blastocysts per sample, repeated two times) in both melatonin-treated and -non-treated groups. In comparison of 2-cell embryos, 175 genes were considered differentially expressed at a fold change (FC) > 5 and fragments per kilobase per million reads (FPKM) > 5 ( Figure 5 and Table S1 ). In the melatonin-treated (SCNT-CROC + K + M) group, 111 genes were upregulated compared with the melatonin-non-treated (SCNT-CROC + K) group. GO-term and KEGG pathway analysis revealed that the addition of melatonin ameliorates cell death-related pathways such as apoptosis, peroxisome, and oxidative phosphorylation ( Figure 5 ). Notably, Deaf1, Fxn, Ppan, Rab10os, Sprr2d, Stag3, Tsen15, and Zfp335, which are involved in cell survival and tissue regeneration, were upregulated in 2-cell embryos from the SCNT-CROC + K + M group. In addition, Ctss, Dffa, Eif3f, Hacl1, Hspbp1, Mob2, Mrpl23, Mrpl33, Pmvk, Slc4a11, and Wbscr22, which are involved in anti-oxidant function, inflammation, and apoptosis, were also highly upregulated. In contrast, the expression of cell death and degeneration-related genes (Atp6v0c, Cd52, Dapk2, Ddit4l, Duoxa2, Nfkbia, Ptgds, Rdh12, and Rnd3) were downregulated in 2-cell embryos from the SCNT-CROC + K + M group (Table S1 ).
As shown in the Table S2 , in comparison of blastocysts, 81 genes were considered differentially expressed at a FC > 2 and FPKM > 5. In the melatonin-treated (SCNT-CROC + K + M) group, 20 genes were upregulated compared with the melatonin-non-treated (SCNT-CROC + K) group. Notably, Amd1, Fam46C, Oxt, and Ppt2, which are involved in cell survival and tissue regeneration, were upregulated in blastocysts from the SCNT-CROC + K + M group. In addition, Gulo and Txnip, which are involved in anti-oxidant function, inflammation, and apoptosis, were also highly upregulated.
In contrast, the expression of many oxidative stressrelated genes (Adh1, Car2, Gsta3, Gstm2, Mb, Phlda2, and S100a1) and cell death and degeneration-related genes (Akr1c13, Amd2, Clu, Hist1h3a, Hspb1, Il1rn, and Nat8) were downregulated in blastocysts from the SCNT-CROC + K + M group. Also, many cell and tumor proliferation-related genes (Efemp1, Glipr1, Lgals4, Plac1, Snora15, Snora 21, Snora 34, and Anxa1) were shown to have decreased expression levels. Moreover, some immune response-related genes (Clec2f, Hrsp12, and Plat) were also shown to be downregulated in the melatonin-treated group (Table S2) . . Beyond these promising applications, SCNT-ESC technologies may help solve the supply problem of human donated oocytes required for the establishment of PSCs. In the present study, we analyzed the developmental capacity of cloned embryos using vitrified oocytes in order to secure a supply of oocytes. The embryonic development of cloned mouse embryos using vitrified oocyte cytoplasm (SCNT-CROC) was decreased and the development was not fully recovered by recent SCNT technology. By RNA-seq analysis, we have evaluated that different expression in apoptosis-and cell-cycle-related genes were found in embryos from the SCNT-CROC group. Addition of melatonin, which has various positive anti-apoptotic and anti-oxidative stress effects during cultivation, was improved in the pre-and post-implantation development of cloned mouse embryos. Moreover, the expression of anti-apoptotic-and cell-survival-related genes was significantly upregulated in the melatonin-treated cloned embryos when compared with the non-treated group.
A high incidence of developmental block has been observed in cloned mammalian embryos and is a major reason for the low efficiency of SCNT technology (Yang et al., 2007) . Several recent reports have suggested that persistence of specific histone methylation interrupts cellular reprogramming of donor nuclei and that addition of histone demethylase enhanced the cloning efficiency in mouse and human SCNT procedures (Chung et al., 2015; Matoba et al., 2014; Matoba and Zhang, 2018). In addition, it has been generally accepted that the vitrification procedure can maintain the developmental capacity of mammalian oocytes after cryopreservation and contribute to the preservation of female fertility (Practice Committees of American Society for Reproductive Medicine and Society for Assisted Reproductive Technology, 2013). However, some effects of cryo-injury still must be overcome in conventional and cloned embryos, even if various technologies are applied (Baek et al., 2017; Yang et al., 2016). To test whether increased histone demethylation has an effect on the recovery of diminished reprogramming potential mediated by cryo-injury, we injected Kdm4a mRNAs into cloned embryos. Similar to our previous reports, Kdm4a mRNAs overcame the developmental block in embryos from the SCNT-FOC and SCNT-CROC groups ( study, to assess the quality of blastocysts, we evaluated ICM and total cell numbers (Kishigami et al., 2006). Although Kdm4a mRNA was injected, the number of ICM in the SCNT-FOC group (using fresh oocyte cytoplasm) was significantly higher than those in the SCNT-CROC group ( Figure 1C ). Also, a significant difference in developmental potential still remained in both SCNT-FOC and SCNT-CROC groups (Table 1) , which suggests that cryo-injury is not fully overcome by this procedure. We performed RNA-seq analysis to identify differential gene expression related to difference in embryonic development between the SCNT-FOC and SCNT-CROC groups. As shown in Figure 2 , gene expression in both groups was similar except for a small number of genes. Of particular note were eight pro-apoptosis-related genes (Cyct, Dapk2, Dffb, Gadd45g, Hint2, Mien1, P2rx7, and Pmaip) and one cell-cycle arrest gene (Gadd45g) that were upregulated in the SCNT-CROC group (Figure 2) . On the other hand, among the 30 gene expression-related genes (0.62% of 4,841 genes) and 61 metabolic process-related genes (0.60% of 10,234 genes) showing different expression in both SCNT-FOC and SCNT-CROC groups, we did not find any gene that downregulated their related functions. Based on these results, we hypothesized that cryo-injury during vitrification may upregulate apoptosis and downregulate embryonic development. Melatonin, well known as an anti-apoptotic and scavenging agent in mammalian embryology (Reiter et al., 2016; Salehi et al., 2014), was able to improve the developmental competence of cloned embryos in the SCNT-CROC group.
Supplementation of melatonin into culture medium increased embryonic development regardless of Kdm4a mRNA injection but showed no effect on overcoming the developmental block (Table 2) . Also, melatonin supplementation decreased apoptosis in cloned mouse embryos (Figure 3) . GO-term and KEGG pathway analysis revealed that the addition of melatonin results in altered expression of genes related to terpenoid backbone biosynthesis, apoptosis, peroxisome, and oxidative phosphorylation, among others. The data suggest that melatonin may confer a beneficial effect on cell survival to SCNT-CROC. Therefore, combining melatonin supplementation and Kdm4a mRNA injection can provide a synergistic effect on the embryonic development of cloned embryos in the SCNT-CROC group. In addition, we analyzed implantation and the ESC derivation of cloned embryos from the SCNT-CROC group after melatonin supplementation. As shown in Figures 4A and S2 , the number of implantation sites at embryonic day 7.5 was significantly increased in the melatonin-treated group. We also found that the derivation efficiency of SCNT-ESCs from cloned embryos using cryopreserved oocytes was improved after melatonin supplementation ( Figure 4B ). More interestingly, we found that the expression of some immune response-related genes (Clec2f, Hrsp12, and Plat) was downregulated following melatonin treatment in in vitro culture, and this downregulation may be related to the increased implantation rate (Table S1 ).
In the present study, we have found that the low developmental efficiency of cloned mouse embryos using cryopreserved oocytes may be due to increased apoptosis and altered gene expression resulting from cryo-injury. Therefore, this decreased developmental competence should be alleviated by the addition of a scavenger agent such as melatonin. This system will also be helpful in the derivation and application of human SCNT-ESC lines by providing steady sources of oocytes, and may reduce the ethical concern related to oocyte donation.
EXPERIMENTAL PROCEDURES

Animals
Eight-to 10-week-old female B6D2F1 mice (Orient-Bio, Gyunggido, Korea) were used for the collection of the recipient oocytes and as SCNT donors. Eight-to 10-week-old female ICR mice were used as the poster mothers of embryo transfer. To induce pseudopregnancy, these mice were mated with vasectomized male mice of the same strain. The protocols for the use of animals in these 
Oocyte Collection
Mice were superovulated by injecting them with 5 IU of pregnant mare serum gonadotropin (Sigma-Aldrich, St. Louis, MO), followed by 5 IU of human chorionic gonadotropin (hCG; Sigma-Aldrich) 48 h later. Oocytes were collected in M2 (Sigma-Aldrich) medium at 14 h after hCG injection, and cumulus cells were denuded with M2 medium containing 0.1% hyaluronidase (Sigma-Aldrich). The cumulus-free oocytes were then cultured in potassium simplex optimized medium (KSOM; Millipore, Darmstadt, Germany) for the experiment. Dispersed cumulus cells were removed by hyaluronidase treatment, diluted in M2 medium, and collected. The pellet was then resuspended in a small volume of 3% (v/v) polyvinylpyrrolidone (PVP) in M2 and kept at 4 C until use.
Oocyte Vitrification and Warming
Quinn's Advantage Medium with HEPES (Sage, Malov, Denmark) with 20% (v/v) Knockout Serum Replacement (KSR; Gibco, Grand Island, NY) was used as the base medium for preparation of all vitrification and warming solutions. Two cryoprotectant agents, a combination of ethylene glycol (EG; Sigma-Aldrich) and dimethylsulfoxide (DMSO; Sigma-Aldrich) were used for the vitrification procedure. MII oocytes were pre-equilibrated with HEPES medium containing 7.5% EG and 7.5% DMSO for 2 min 30 s. Pre-equilibrated oocytes were then placed and equilibrated in the same volume of HEPES medium supplemented with 15% EG, 15% DMSO, and 0.5 M sucrose (Sigma-Aldrich) for 20 s. Equilibrated oocytes were loaded onto electron microscopic (EM) copper grids (EM Grid; PELCO, Redding, CA) and plugged into slush nitrogen (SN 2 ) using Vit-master (IMT; Ness Ziona, Israel). Vitrified oocytes were stored in an LN 2 tank. For warming, vitrified oocytes were warmed by a four-step method. The EM grids were sequentially transferred to 0. 
Preparation of Kdm4a mRNA
In vitro transcription was performed as described previously (Chung et al., 2015). In brief, full-length mouse Kdm4a/Jhdm3a cDNA was cloned into a pcDNA3.1 plasmid containing poly(A) 83 at the 3 0 end of the cloning site by using an In-Fusion Kit (Clonetech #638909). Messenger RNA was synthesized from the linearized template plasmids by in vitro transcription using a mMESSAGE mMACHINE T7 Ultra Kit (Life Technologies #AM1345). The synthesized mRNA was dissolved in nuclease-free water. The concentration of mRNA was measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies); aliquots of mRNA were stored at À80 C until use.
SCNT and Embryonic Development
After incubation at 37 C, the cumulus of fresh or vitrified/warmed oocytes was denuded and fresh cumulus cells were also collected as nuclear donors. The fresh and vitrified/warmed oocytes were enucleated in M2 medium containing 5 mg/mL cytochalasin B. For nuclear transfer, cumulus cells were injected into enucleated oocytes in M2 medium using a piezo-driven micromanipulator (Primetech, Tsuchiura-shi, Japan). After nuclear transfer, the reconstructed embryos were activated for 6 h by 10 mM SrCl 2 , 2 mM EGTA, and 5 mg/mL cytochalasin B in M16 (Millipore) medium and then cultured in KSOM in a humidified atmosphere of 5% CO 2 at 37 C. The group of cloned embryos from SCNT using fresh oocyte cytoplasm (FOC) was referred as SCNT-FOC, and the group using vitrified/warmed (cryopreserved/thawed) oocyte cytoplasm was referred to as SCNT-CROC. In the first-round experiment, cloned embryos of both groups were injected with $10 pL of water (control) or 2 mg/mL Kdm4a mRNA using a piezo-driven micromanipulator. In the second-round experiment, cloned embryos from the SCNT-CROC group were first injected with Kdm4a 
Detection of DNA Fragmentation by TUNEL
DNA fragmentation was detected using TUNEL staining (in situ Cell Death Detection Kit, Roche, Indianapolis, IN). According to the instruction manual, SCNT-derived blastocysts were washed three times in 0.1% PVA in Dulbecco's PBS. The embryos were then incubated in TUNEL reaction medium at 37 C in the dark for 1 h. DNA staining with 1 mg/mL Hoechst 33342 (bis-benzimide, Sigma) was used for nuclear counterstaining. Signals in embryos were observed with a confocal microscope (Zeiss LSM880).
Analysis of ROS Level
In the SCNT-CROC + K group, embryos at the morula or blastocyst stages were treated with or without melatonin and incubated in culture medium containing 5 mM CellROX Oxidative Stress Reagents (Molecular Probes, Eugene, OR) for 30 min, then washed two times with 0.1% PVA-D-PBS. Embryos were examined under a fluorescence confocal microscope (Zeiss LSM880). The recorded fluorescence intensities were analyzed using ImageJ software. The fluorescence pixel value of the embryos was measured within a constant area from different embryos' cytoplasmic regions. Background fluorescent values were subtracted from the final values before analysis of statistically significant differences between the groups. The experiment was replicated three times with 5-10 embryos in each replicate.
RNA-Seq Analysis of Cloned Embryos and Blastocysts
We performed two rounds of RNA-seq analysis. In the first round, gene expression was assessed in 2-cell embryos between SCNT-FOC + K and SCNT-CROC + K (100 embryos per sample, repeated three times). In the second round, gene expression was assessed in 2-cell embryos and blastocysts between SCNT-CROC + K and SCNT-CROC + K + M (50 2-cell embryos and 50 blastocysts per sample, repeated two times). Complementary DNAs (cDNAs) were amplified using a SMARTer Ultra Low Input RNA cDNA preparation kit (Takara, 634890) according to the manufacturer's instructions. The cDNAs were then fragmented into approximately 200-bp fragments using an M220 sonicator (Covaris). The fragmented cDNAs were end-repaired and adapter-ligated. The sequencing libraries were prepared using a ScriptSeq v2 kit (Illumina) according to the manufacturer's instructions. Single-end sequencing was performed on a HiSeq2500 (Illumina), and reads were mapped to the mm9 mouse genome using STAR (v2.5.2b, https://github.com/ alexdobin/STAR). After mapping, FPKM was calculated by Cufflinks (v2.2.1) using a default option. Genes were considered differentially expressed at FC >2-5 and FPKM > 5. KEGG pathway analysis was visualized by ClueGO package. Gene set enrichment analysis was also used to identify biological function of the DEGs. An R (v3.3.2) package was used for statistical analyses and scatterplot generation.
Embryo Transfer and Implantation Monitoring
Reconstructed embryos cultured to the blastocyst stage under melatonin treatment or non-treatment conditions (SCNT-CROC + K and SCNT-CROC + K + M groups) were transferred into the uteri of 2.5-day pseudopregnant female ICR mice that had been mated with vasectomized male ICR mice. Each groups are transplanted into the left (SCNT-CROC + K) and right (SCNT-CROC + K + M) uterus in the same mouse. Females were subsequently checked for implantation rate at 7.5 days post coitus. For visualization of implantation, mice were euthanized, the intact uterus was excised into normal saline, adhering fat was dissected away, and the tissue was photographed.
Derivation of Mouse Embryonic Stem Cells from SCNT Blastocysts
Hatched blastocysts obtained from both groups (SCNT-CROC + K and SCNT-CROC + K + M) were placed on mitotic inactivated mouse embryonic fibroblast (MEF) feeder cells in mESC culture medium to form outgrowths. We used DMEM/F12 containing 20% KSR, 0.1 mM b-mercaptoethanol, 1% non-essential amino acids, 100 units/mL penicillin, 100 mg/mL streptomycin (all products from Gibco/Invitrogen, Grand Island, NY), and 1.5 3 10 3 units/mL recombinant mouse leukemia inhibitory factor (Chemicon, Temecula, CA) for mESC culture medium. Outgrowths were transferred onto new MEF feeder cells, mechanically at first, then passaged using trypsin-EDTA. All of the established mESC lines were monitored and then characterized by morphology and alkaline phosphatase staining. Alkaline phosphatase activity was assessed by histochemical staining. Colonies were fixed in 4% paraformaldehyde at room temperature for 1 min, washed twice with PBS, and stained with an alkaline phosphatase substrate solution (10 mL of FRV-alkaline solution, 10 mL of naphthol AS-BI alkaline solution; alkaline phosphatase kit, Sigma-Aldrich) for 30 min at room temperature. Alkaline phosphatase activity was detected colorimetrically by light microscopy.
Statistical Analysis
All the experiments were repeated at least three times. The results are presented as mean or mean ± SEM. Embryonic developments were analyzed by one-way ANOVA by Duncan's test using SAS software and implantation, and ESC-derivation rates were analyzed by the Chi-square test. p < 0.05 was regarded as statically significant.
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